Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.(b)(4).Title of article: freestyle root replacement for complex destructive aortic valve endocarditis citation: j thorac cardiovasc surg 10.1016/j.Jtcvs.2013.05.014 issue number: 147:1265-70 authors: anneliese heinz, md, julia dumfarth, md, elfriede ruttmann-ulmer, md, michael grimm, md, and ludwig c.M¿uller, md.The available ahead of print date (b)(6) 2013 used for event date.
|
Medtronic received information via literature review that a study was performed over a 10 year period to evaluate freestyle aortic root replacement for severe, destructive valve endocarditis.The study population included 32 patients, predominantly male with a mean age of 61 years, all of whom were implanted with medtronic freestyle aortic root replacement (serial numbers not provided).Among all patients, 14 deaths occurred, which included: multi-organ failure, cardiac decompensation, ischemic heart failure, acute cardiac death, acute myocardial infarction, unexplained sudden death, brainstem infarction, staphylococcus sepsis, and unknown reasons.Of these deaths, none were directly associated with / attributed to the valve or its function.Among all patients, 19 adverse events occurred, which included: reoperation for bleeding due to coagulopathy, postoperative mechanical circulatory support with intra-aortic balloon pump and extracorporeal membrane oxygenation, permanent pacemaker for new heart block, temporary hemo- filtration for new-onset acute renal failure, ischemic stroke caused by multiple embolic lesions of different age.Three (3) patients underwent reoperation: one (1) after 3 years and 1 after 12 years for xenograft degeneration due to severe calcific stenosis and 1 after 3 years for recurrent endocarditis.No additional adverse patient effects were reported.
|